INNOPHARMAINC.COM

Innopharma, Inc. |

News & Media. 8221; InnoPharma is dedicated to developing complex generic and innovative specialty pharmaceutical drug products. In a high quality, time efficient and cost effective manner. For us, providing value add to patients, prescribers and distributors is at the core of our business model. “. InnoPharma, Inc is now a wholly owned subsidiary of Pfizer, Inc’. InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN.

http://www.innopharmainc.com/

OVERVIEW OF innopharmainc.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR INNOPHARMAINC.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 16 reviews

5 star

9

4 star

4

3 star

2

2 star

0

1 star

1

Hey there! Start your review of innopharmainc.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT INNOPHARMAINC.COM

Innopharma Inc.

Dr. Navneet Puri

33, Fr●●●●●● Drive

Brid●●●●ater , New Jersey, 08807

US

1.90●●●●4479

np●●●●●@yahoo.com

View this contact

Innopharma Inc.

Dr. Navneet Puri

33, Fr●●●●●● Drive

Brid●●●●ater , New Jersey, 08807

US

1.90●●●●4479

np●●●●●@yahoo.com

View this contact

Innopharma Inc.

Dr. Navneet Puri

33, Fr●●●●●● Drive

Brid●●●●ater , New Jersey, 08807

US

1.90●●●●4479

np●●●●●@yahoo.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2004 January 08
UPDATED: 2013 December 16
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

21

YEARS
10

MONTHS
7

DAYS

NAME SERVERS

1: ns53.domaincontrol.com
2: ns54.domaincontrol.com

REGISTRAR

PDR LTD. D/B/A PUBLICDOMAINREGISTRY.COM

WHOIS : whois.PublicDomainRegistry.com

REFERRED : http://www.PublicDomainRegistry.com

CONTENT

PAGES IN
THIS WEBSITE

6

SSL

EXTERNAL LINKS

5

SITE IP

216.146.46.11

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Innopharma, Inc. | | innopharmainc.com Reviews

<META> DESCRIPTION

News & Media. 8221; InnoPharma is dedicated to developing complex generic and innovative specialty pharmaceutical drug products. In a high quality, time efficient and cost effective manner. For us, providing value add to patients, prescribers and distributors is at the core of our business model. “. InnoPharma, Inc is now a wholly owned subsidiary of Pfizer, Inc’. InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN.

<META> KEYWORDS

1 navigation

2 what we do

3 pipeline

4 marketed products

5 team

6 mission statement

7 latest news

8 view all

9 learn more

10 coupons

CONTENT

Page content here

KEYWORDS ON PAGE

navigation,what we do,pipeline,marketed products,team,mission statement,latest news,view all,learn more

SERVER

cloudflare

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Innopharma, Inc. | | innopharmainc.com Reviews

https://innopharmainc.com

News & Media. 8221; InnoPharma is dedicated to developing complex generic and innovative specialty pharmaceutical drug products. In a high quality, time efficient and cost effective manner. For us, providing value add to patients, prescribers and distributors is at the core of our business model. “. InnoPharma, Inc is now a wholly owned subsidiary of Pfizer, Inc’. InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN.

INTERNAL PAGES

innopharmainc.com

1

What We Do | Innopharma, Inc.

http://innopharmainc.com/who-we-are

News & Media. InnoPharma focuses on developing complex generic and innovative specialty pharmaceutical products in injectable and ophthalmic dosage forms. InnoPharma has a comprehensive R&D facility in Piscataway NJ. The laboratories can handle compounding (including containment facilities), filling, sterilization, analytical and stability. Lyophilization, homogenization, milling, and micronization. Cytotoxics, steroids, and hormones. Small molecules, peptides, lipids, and carbohydrates.

2

Pipeline | Innopharma, Inc.

http://innopharmainc.com/who-we-are/pipeline-2

News & Media. InnoPharma’s generic program is targeted on developing complex drug products that incorporate more than one of the below:. Difficult to develop for technical and scientific reasons, including molecules with solubility, stability, characterization and synthesis complexities. Niche area of use. Complicated bio-equivalency or clinical studies. InnoPharma currently has 21 generic products pending at the FDA 1 of which is confirmed FTF. The submitted ANDAs cover $5B in US brand market sales.

3

InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada | Innopharma, Inc.

http://innopharmainc.com/innopharma-announces-launch-of-olanzapine-for-injection-10mgvial-in-canada

News & Media. InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada. InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada. As the developer of this generic injectable drug, InnoPharma has entered into an agreement with Sandoz Canada Inc., pursuant to which Sandoz Canada will make, use, sell, market and distribute Olanzapine Injection in Canada. For Further Information Contact:. John C. Deighan. Senior Director, Finance. About InnoPharma, Inc. InnoPharma Inc&...

4

Marketed Products | Innopharma, Inc.

http://innopharmainc.com/who-we-are/marketed-products

News & Media. InnoPharma focuses on difficult to make products and has worked with the top 3 generic pharmaceutical companies to commercialize its products. There are 9 products on the market. The average approval time is only 25 months. Being first to market or first-to-file is what the generic industry strives for, greater than 75% of InnoPharma’s marketed products were first approvals and have only 1 competitor in the market. This status makes it a stand-out leader in the generic space.

5

News & Media | Innopharma, Inc.

http://innopharmainc.com/news-media

News & Media. News & Media. InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN. Posted on Aug 29, 2014. Piscataway, N.J., August 29, 2014 InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai Inc.’s DACOGEN . (more…). InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada. Posted on Jul 30, 2014.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

athyrium.com

Athyrium Capital Management | Athyrium Opportunities Fund (AOF)

http://www.athyrium.com/athyrium-opportunities-fund.php

What is Structured Capital. Athyrium Opportunities Fund (AOF). Ironwood and Forest Laboratories. SynCardia Systems, Inc. Tria Beauty, Inc. Specialty Injectable and Ophthalmic Generic Pharmaceuticals. Horizon Pharma, Inc. Various NSAIDs and ACTIMMUNE. Universal Biosensors, Inc. LifeScan (J&J) and Siemens. Point of Care (POC) Diagnostics. Pernix Therapeutics Holdings, Inc. Synarc-Biocore Holdings, LLC. Specialty Clinical Research Services. Alamo Pharma Services, Inc. Lannett Company, Inc.

karsai.hu

Referenciáink - KARSAI ZRT.

http://www.karsai.hu/referenciak

Hőre keményedő fröccsöntés, sajtolás. Vákuum-, és préslégformázás. Sleevezés, címkézés, lézergravírozás. Lemezmegmunkálás, acél hideg alakítása. Szerszámtervezés, 3D prototípus és szerszámgyártás. Karsai Műanyagipari Holding Zrt. Karsai Alba Kft. - Körmend. Karsai Hargita Plast Kft. Vegye fel velünk a kapcsolatot!

karsai.upsolution.hu

Referenciáink - KARSAI ZRT.

http://www.karsai.upsolution.hu/referenciak

Hőre keményedő fröccsöntés, sajtolás. Vákuum-, és préslégformázás. Sleevezés, címkézés, lézergravírozás. Lemezmegmunkálás, acél hideg alakítása. Szerszámtervezés, 3D prototípus és szerszámgyártás. Karsai Műanyagipari Holding Zrt. Karsai Alba Kft. - Körmend. Karsai Hargita Plast Kft. Vegye fel velünk a kapcsolatot!

tm-partners.com

Thomas McNerney & Partners

http://www.tm-partners.com/news/071614.html

PFIZER TO ACQUIRE INNOPHARMA, INC. InnoPharma Has Established Track Record in the Development of Hard-to-Make, Differentiated, Sterile Injectable Products. Portfolio of 10 Approved Products and Pipeline of More Than 30 Products in Development; 19 Pending Approval with the United States Food and Drug Administration. Under the terms of the agreement, Pfizer will acquire InnoPharma for an upfront cash payment of $225 million, with up to $135 million of contingent milestone payments. Established in 2005, Inn...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

5

OTHER SITES

innopharma.it

CRO | InnoPharma

Esperienza e turnover del personale. Servizi fase I IV. INNOPHARMA, una CRO fondata nel 1995, ha le risorse umane, gli strumenti e la cultura aziendale per rispondere alle più difficili sfide nel settore dello sviluppo farmaceutico e delle biotecnologie. Il nostro gruppo ha la capacità e l’esperienza per seguire trials clinici e progetti di sviluppo sia in campo nazionale che internazionale. Possiamo fornire servizi di sviluppo in proprio o essere parte di soluzioni integrate. InnoPharma S.r.l.

innopharma.net

Innovaciones Pharmaceuticas

Para sus consultas, comentarios y sugerencias por favor escríbanos. Será un placer atender a sus preguntas. Central, Alajuela, Costa Rica.

innopharma.ps1.su

INNOPHARMA webcard n2506 стр.0

Автоматизированная система ведения титульной информации об участниках рынка интеллектуальных компьютерных технологий,. И не только . Кнопка на страницу фирмы в ежемесячной энциклопедии. Телефон можно уточнить у администратора домена. 125190, Москва, а/я 238. Свидетельство о регистрации периодического издания. N 215 от 19.09.1990. ООО Редакция журнала Персональные Программы. Personal Software Magazine WebCard. Обновления и архивы: http:/ innopharma.ps1.su. Http:/ innopharma.p-pp.ru. Если Вы одобряете наш ...

innopharma.sk

Innopharma producer & manufacturer of vitamins & health supplements - Homepage

Thank you for visiting us. At PLMA International 28th - 29th May 2013 in Amsterdam. Great tasting Award for Innopharma. Innopharma has officially received, for the fifth time in a row, another thumbs up for the great taste of Vitamin C Chewable tablets! An independent panel awarded the products with the highest possible score above all other tablets! Innopharma and Principle Healthcare have produced a new corporate video. Watch the video now. Located in the heart of Europe in Slovakia,. In a recently pub...

innopharmachina.com

中国地方で活動する興信所情報

innopharmainc.com

Innopharma, Inc. |

News & Media. 8221; InnoPharma is dedicated to developing complex generic and innovative specialty pharmaceutical drug products. In a high quality, time efficient and cost effective manner. For us, providing value add to patients, prescribers and distributors is at the core of our business model. “. InnoPharma, Inc is now a wholly owned subsidiary of Pfizer, Inc’. InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN.

innopharmainternational.com

CRO | InnoPharma

Http:/ courtesy.register.it/index.html.

innopharmalabs.com

Welcome | Innopharma

PAT Solutions and Pharmaceutical Courses Innopharma. Innopharma is the award winning industry led education. Institute for the pharmaceutical, medtech and food industries. Pharmaceutical, biopharmaceutical, and food science accredited qualifications for all levels from operator to executive. Process Analytical Technology Solutions for Development and Advanced Manufacturing for Pharmaceutical, Chemical, and Food Industries. Want to call, e-mail or find out where we are located. Three Rock Road,.

innopharmaplatform.com

Innopharma

Una iniciativa desde Galicia para el descubrimiento temprano de fármacos.

innopharmascreen.com

팀장닷컴

신청하신 웹 호스팅 서비스의 셋업이 완료되었습니다! 에서 서비스 관련 각종 정보 조회 및 관리를 할 수 있습니다. 마이페이지]의 서비스 관련 주요 기능은 다음과 같습니다. SSH/FTP 접속 IP 주소 관리. 일일 전송량 조회 및 초기화. 이 외에도 다양한 기능이 준비되어 있으니 많은 이용 바랍니다. 모바일 전용 홈페이지는 m.innopharmascreen.com. 마이페이지] - [첫페이지 관리]. 스마트폰으로 접속시 모바일 전용 홈페이지로 접속되도록 설정할 수 있습니다. 이용 중 궁금하신 사항은 [자주 묻는 질문]이나 [이용 문의]를 이용해 주시기 바랍니다. 도메인 등록 및 네임서버 변경에 대해 알려드립니다. 1 zcbz(무료 도메인)를 신청하신 경우, 지금 바로 도메인을 사용할 수 있습니다. 2 팀장닷컴에 도메인을 등록하신 경우, 24시간 이내에 도메인을 사용할 수 있습니다. 3 타사에 도메인을 등록하신 경우, 네임서버를 아래와 같이 변경하고 1 2일 후 사용이 가능합니다.

innopharmax.com

因華生技製藥股份有限公司 -

這個頁面上的內容需要較新版本的 Adobe Flash Player。 2017/12/19] New Indication for Innomustine. TAIPEI, Taiwan, R.O.C.—Dec. 01, 2017 - InnoPharmax Inc. Inc. announced that the Taiwan Food and Drug Administrati . 2017/07/12] Innopharmax signed distribution contract for Inpheno Tablets with BL&H Co. Ltd. for Korea market. Innopharmax signed distribution contract for Inpheno Tablets with BL&H Co. Ltd. for Korea market. 2016/05/31] InnoPharmax will participate in ASCO Annual Meeting 2016 in Chicago (Booth No. 21096). InnoPh...